ERLINA 10/5MG TAB (14s)

ERLINA 10/5mg Tablets (14s) combine empagliflozin 10mg and linagliptin 5mg, offering a powerful dual-action treatment for type 2 diabetes mellitus. This combination helps regulate blood glucose by increasing insulin release, reducing glucose production, and promoting glucose excretion through urine. ERLINA effectively supports glycemic control, helps prevent diabetic complications, and contributes to overall metabolic health when used alongside a balanced diet and regular exercise.

Uses:

• Used for the management of type 2 diabetes in adults.

• Helps control high blood sugar levels and reduce HbA1c.

• Supports prevention of cardiovascular and kidney complications linked with diabetes.

Benefits:

• Dual mechanism of action for better glucose control.

• Promotes weight reduction and improved energy balance.

• Low risk of hypoglycemia when used alone.

• Once-daily convenient dosing for better patient compliance.

Side Effects:

• Common: Increased urination, thirst, nasal congestion, or cough.

• Occasionally: Urinary tract infections, hypoglycemia (when combined with other antidiabetics), or digestive discomfort.

• Rarely: Allergic reactions or dehydration in sensitive individuals.